These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 18281962)

  • 1. Combining pharmacophore fingerprints and PLS-discriminant analysis for virtual screening and SAR elucidation.
    Askjaer S; Langgård M
    J Chem Inf Model; 2008 Mar; 48(3):476-88. PubMed ID: 18281962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virtual screening of biogenic amine-binding G-protein coupled receptors: comparative evaluation of protein- and ligand-based virtual screening protocols.
    Evers A; Hessler G; Matter H; Klabunde T
    J Med Chem; 2005 Aug; 48(17):5448-65. PubMed ID: 16107144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fuzzy tricentric pharmacophore fingerprints. 1. Topological fuzzy pharmacophore triplets and adapted molecular similarity scoring schemes.
    Bonachéra F; Parent B; Barbosa F; Froloff N; Horvath D
    J Chem Inf Model; 2006; 46(6):2457-77. PubMed ID: 17125187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fuzzy pharmacophore models from molecular alignments for correlation-vector-based virtual screening.
    Renner S; Schneider G
    J Med Chem; 2004 Sep; 47(19):4653-64. PubMed ID: 15341481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-based drug discovery using GPCR homology modeling: successful virtual screening for antagonists of the alpha1A adrenergic receptor.
    Evers A; Klabunde T
    J Med Chem; 2005 Feb; 48(4):1088-97. PubMed ID: 15715476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fuzzy tricentric pharmacophore fingerprints. 2. Application of topological fuzzy pharmacophore triplets in quantitative structure-activity relationships.
    Bonachéra F; Horvath D
    J Chem Inf Model; 2008 Feb; 48(2):409-25. PubMed ID: 18254617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Scaffold hopping through virtual screening using 2D and 3D similarity descriptors: ranking, voting, and consensus scoring.
    Zhang Q; Muegge I
    J Med Chem; 2006 Mar; 49(5):1536-48. PubMed ID: 16509572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combining ethnopharmacology and virtual screening for lead structure discovery: COX-inhibitors as application example.
    Rollinger JM; Haupt S; Stuppner H; Langer T
    J Chem Inf Comput Sci; 2004; 44(2):480-8. PubMed ID: 15032527
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
    Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
    Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for generating less toxic P-selectin inhibitors: pharmacophore modeling, virtual screening and counter pharmacophore screening to remove toxic hits.
    Ananthula RS; Ravikumar M; Pramod AB; Madala KK; Mahmood SK
    J Mol Graph Model; 2008 Nov; 27(4):546-57. PubMed ID: 18993099
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virtual screening against Mycobacterium tuberculosis dihydrofolate reductase: suggested workflow for compound prioritization using structure interaction fingerprints.
    Kumar A; Siddiqi MI
    J Mol Graph Model; 2008 Nov; 27(4):476-88. PubMed ID: 18829358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A common reference framework for analyzing/comparing proteins and ligands. Fingerprints for Ligands and Proteins (FLAP): theory and application.
    Baroni M; Cruciani G; Sciabola S; Perruccio F; Mason JS
    J Chem Inf Model; 2007; 47(2):279-94. PubMed ID: 17381166
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T; Giegerich C; Evers A
    J Med Chem; 2009 May; 52(9):2923-32. PubMed ID: 19374402
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating structure- and ligand-based virtual screening: comparison of individual, parallel, and fused molecular docking and similarity search calculations on multiple targets.
    Tan L; Geppert H; Sisay MT; Gütschow M; Bajorath J
    ChemMedChem; 2008 Oct; 3(10):1566-71. PubMed ID: 18651695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parallel screening: a novel concept in pharmacophore modeling and virtual screening.
    Steindl TM; Schuster D; Laggner C; Langer T
    J Chem Inf Model; 2006; 46(5):2146-57. PubMed ID: 16995745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beyond the virtual screening paradigm: structure-based searching for new lead compounds.
    Schlosser J; Rarey M
    J Chem Inf Model; 2009 Apr; 49(4):800-9. PubMed ID: 19354328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of phosphodiesterase-1 and 5 dual inhibitors by a ligand-based virtual screening optimized for lead evolution.
    Yamazaki K; Kusunose N; Fujita K; Sato H; Asano S; Dan A; Kanaoka M
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1371-9. PubMed ID: 16337379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rendering conventional molecular fingerprints for virtual screening independent of molecular complexity and size effects.
    Nisius B; Bajorath J
    ChemMedChem; 2010 Jun; 5(6):859-68. PubMed ID: 20425878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based shape pharmacophore modeling for the discovery of novel anesthetic compounds.
    Ebalunode JO; Dong X; Ouyang Z; Liang J; Eckenhoff RG; Zheng W
    Bioorg Med Chem; 2009 Jul; 17(14):5133-8. PubMed ID: 19520579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.